BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 25, 2017
View Archived Issues
NewLink Genetics synthesizes indoximod prodrug for cancer immunotherapy
Read More
Pan-TRK inhibitor CH-7057288 active against TRK fusion-driven cancer in vivo
Read More
Discovery and clinical data detailed for IDO-1 inhibitor BMS-986205
Read More
DS-5141 designated under Japanese Sakigake designation system
Read More
Phase Ib/II topline results for Resolaris in early-onset facioscapulohumeral muscular dystrophy
Read More
Preliminary results from the SIGNAL trial of VX-15 in Huntington's disease
Read More
Cara reports encouraging data from phase I safety trial of intravenous CR-845
Read More
Kissei discontinues development of KCT-0809 for dry eye associated with Sjogren's syndrome
Read More
BD set to acquire Bard
Read More
CMV pp65-LAMP vaccination results in survival benefit in patients with glioblastoma
Read More
Akari presents new data on Coversin
Read More
Clinigen and Onxeo agree to launch managed access program for Beleodaq in Europe
Read More
Xoma reports phase II results for X-213 in prolactin inhibition
Read More
EMA committee recommends approval of Skilarence for psoriasis
Read More
Auris Medical reports results from Keyzilen extension study AMPACT2 in acute inner ear tinnitus
Read More
MONARCH 3 trial of abemaciclib in breast cancer meets primary endpoint
Read More
Aducanumab designated under Japanese Sakigake designation system for Alzheimer's disease
Read More
Japanese Sakigake designation awarded to Opdivo for biliary tract cancer
Read More
Subgroups benefit from lefitolimod in phase II IMPULSE trial in small-cell lung cancer
Read More
Denovo gains exclusive worldwide license to liafensine
Read More
CSPC Zhongqi Pharmaceutical Technology identifies MAPK14 inhibitors
Read More
Rhythm Pharmaceuticals patents melanocortin MC4 receptor agonists
Read More
Novartis and Amgen expand commercialization agreement for AMG-334
Read More
Five drugs assigned target products under Japanese Sakigake designation system
Read More
Cetirizine evaluated as add-on treatment for neuromyelitis optica
Read More